Concepedia

Publication | Open Access

Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease

DOIFull Paper Access

480

Citations

21

References

2013

Year

J.‐F. Yale, George L. Bakris, Bertrand Cariou, Dennis K. Yue, Elias David‐Neto, Liwen Xi, K. Figueroa, Ewa Wajs, Keith Usiskin, Gary Meininger
Diabetes Obesity and Metabolism

Abstract

Canagliflozin improved glycaemic control and was generally well tolerated in subjects with T2DM and Stage 3 CKD.

References

YearCitations

Page 1